Catecholaminergic polymorphic ventricular tachycardia Bjorn C. Knollmann (Vanderbilt University School of Medicine, Nashville, USA; bjorn.knollmann@vanderbilt.edu) 13. Idiopathic ventricular fibrillation and early repolarization Pieter Postema (Academic Medical Center, Amsterdam, The Netherlands; p.g.postema@amc.uva.nl) 14. Atrial fibrillation Dierk Thomas (Heidelberg, Germany) 15. Pulmonary arterial hypertension Horst Olschewski (Ludwig Boltzmann Institute for Lung Vascular Research, Medical University of Graz, Austria; horst.olschewski@medunigraz.at) 16. Genetic testing for inheritable cardiac channelopathies Julien Barc (l'institut du thorax, Nantes, France; julien.barc@inserm.fr) Part C: Research into cardiac channelopathies: new avenues 17. Novel imaging techniques in cardiac ion channel research Eli Rothenberg (Department of Biochemistry and Molecular Pharmacology, New York, USA; Eli. Rothenberg@nyumc.org) 18.
Text of Note
HCN channels and cardiac pacemaking Mirko Baruscotti (Department of Biomolecular Sciences and Biotechnology, University of Milan, Italy; mirko.baruscotti@unimi.it) 8. (Dys)regulation of ionic homeostasis: relevance for cardiac arrhythmias (including ryanodine receptor channelopathies, etc) Luigi Venetucci (Institute of Cardiovascular Sciences, University of Manchester, UK; luigi.venetucci@manchester.ac.uk) Part B: Cardiac channelopathies: clinical and genetic findings 9. Long QT syndrome (including Timothy syndrome), short QT syndrome Lia Crotti (Department of Molecular Medicine, University of Pavia, Pavia, Italy; liacrotti@yahoo.it) 10. Brugada syndrome Koonlawee Nademanee (The Pacific Rim Electrophysiology Research Institute, Los Angeles, USA; wee@pacificrimep.com) 11. Sinus node disease and Lev-Lenègre syndrome-progressive cardiac conduction disease Patrick Schweizer (Heidelberg, Germany; patrick.schweizer@med.uni-heidelberg.de) 12.
Text of Note
IPSC-CM: towards personalized therapeutic strategies? Alessandra Moretti (Technical University of Munich, Germany; amoretti@mytum.de) 19. Computational modeling in cardiac channelopathy research Blanca Rodriguez (Department of Computer Science, University of Oxford, Oxford, UK; blanca.rodriguez@cs.ox.ac.uk) 20. Identification of disease modifiers in cardiac channelopathies Elisabeth Lodder/Connie Bezzina (Academic Medical Center, Amsterdam, The Netherlands; e.m.lodder@amc.uva.nl) 21. Transgenic animal models of cardiac channelopathies -- benefits and limitations Katja Odening (Universitäts-Herzzentrum Freiburg, Germany; katja.odening@uniklinik-freiburg.de).
Text of Note
Part A: (Dys)function of cardiac ion channels 2. The electrophysiological basis of cardiac conduction and repolarization (include also: Distribution of ion channels in the heart (atrium vs ventricle, conduction system versus working myocardium, Purkinje, transmural distribution)) Jules Hancox (University of Bristol, UK; Jules. Hancox@bristol.ac.uk) 3. Novel insights into ion channel complexity and diversity: relevance for cardiac channelopathies (interacting proteins, subcellular distribution, non-electrogenic effects, electro-mechanical overlap, impact on other organs, etc). Hugues Abriel (Bern, CH) 4. Cardiac sodium channel structure and (dys)function C.A. Remme (Amsterdam, NL) 5. Potassium channels in the heart: structure and (dys)function Nicole Schmitt (Copenhagen, Denmark; nschmitt@sund.ku.dk) 6. Calcium channels and their roles in cardiac electrophysiology Niels Voigt (Göttingen; Germany; niels-voigt@t-online.de) 7.
0
0
0
0
SUMMARY OR ABSTRACT
Text of Note
This book provides an expert overview on ion channel-related arrhythmia mechanisms, and describes important advances in our understanding of how ion channel dysfunction causes cardiac disease. Both, scientific findings and clinical implications are presented and discussed by scientists who have considerably contributed to the field. The book is organized in three parts: part I treats the molecular and electrophysiological mechanisms of function and dysfunction of ion channels, part II focuses on genetics and clinical findings, whereas part III describes novel research techniques, the use of stem cells and animal models and provides an outlook on future investigations and applications. The book is written for scientists in Cardiovascular Biology and Neuroscience and will be of general interest to Medical Doctors in Cardiology, Cardiac Electrophysiology and related disciplines.
ACQUISITION INFORMATION NOTE
Source for Acquisition/Subscription Address
Springer Nature
Stock Number
com.springer.onix.9783319778129
OTHER EDITION IN ANOTHER MEDIUM
Title
Channelopathies in heart disease.
International Standard Book Number
9783319778112
TOPICAL NAME USED AS SUBJECT
Ion channels.
Pathology, Molecular.
Biomedical engineering.
Cardiovascular medicine.
Cellular biology (cytology)
Ion channels.
Life sciences: general issues.
MEDICAL-- Physiology.
Pathology, Molecular.
SCIENCE-- Life Sciences-- Human Anatomy & Physiology.